113 related articles for article (PubMed ID: 16313886)
1. The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity.
Mishra S; Murphy LJ
Biochem Biophys Res Commun; 2006 Jan; 339(2):726-30. PubMed ID: 16313886
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein.
Mishra S; Melino G; Murphy LJ
J Biol Chem; 2007 Jun; 282(25):18108-18115. PubMed ID: 17478427
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of histones by tissue transglutaminase.
Mishra S; Saleh A; Espino PS; Davie JR; Murphy LJ
J Biol Chem; 2006 Mar; 281(9):5532-8. PubMed ID: 16407273
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase.
Mishra S; Murphy LJ
J Biol Chem; 2004 Jun; 279(23):23863-8. PubMed ID: 15069073
[TBL] [Abstract][Full Text] [Related]
5. TG2 protects neuroblastoma cells against DNA-damage-induced stress, suppresses p53 activation.
Tucholski J
Amino Acids; 2010 Jul; 39(2):523-32. PubMed ID: 20112034
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma.
Kim GR; Kang JH; Kim HJ; Im E; Bae J; Kwon WS; Rha SY; Chung HC; Cho EY; Kim SY; Kim YC
Bioorg Chem; 2024 Feb; 143():107061. PubMed ID: 38154386
[TBL] [Abstract][Full Text] [Related]
7. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
[TBL] [Abstract][Full Text] [Related]
8. Bcr is a substrate for Transglutaminase 2 cross-linking activity.
Yi SJ; Groffen J; Heisterkamp N
BMC Biochem; 2011 Feb; 12():8. PubMed ID: 21310073
[TBL] [Abstract][Full Text] [Related]
9. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
[TBL] [Abstract][Full Text] [Related]
10. Identification of transglutaminase 2 kinase substrates using a novel on-chip activity assay.
Jung SH; Kong DH; Jeon HY; Ji SH; Han ET; Park WS; Hong SH; Kim MS; Kim YM; Ha KS
Biosens Bioelectron; 2016 Aug; 82():40-8. PubMed ID: 27040940
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2 expression levels regulate sensitivity to cystamine plus TRAIL-mediated apoptosis.
Jang JH; Park JS; Lee TJ; Kwon TK
Cancer Lett; 2010 Jan; 287(2):224-30. PubMed ID: 19632032
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
13. Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity.
Kanchan K; Ergülen E; Király R; Simon-Vecsei Z; Fuxreiter M; Fésüs L
Biochem J; 2013 Nov; 455(3):261-72. PubMed ID: 23941696
[TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of transglutaminase 2 by PKA at Ser216 creates 14-3-3 binding sites.
Mishra S; Murphy LJ
Biochem Biophys Res Commun; 2006 Sep; 347(4):1166-70. PubMed ID: 16870138
[TBL] [Abstract][Full Text] [Related]
16. Detection of Transglutaminase 2 conformational changes in living cell.
Pavlyukov MS; Antipova NV; Balashova MV; Shakhparonov MI
Biochem Biophys Res Commun; 2012 May; 421(4):773-9. PubMed ID: 22548802
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide-Stimulated Transglutaminase 2 Expression Enhances Endocytosis Activity in the Mouse Microglial Cell Line BV-2.
Kawabe K; Takano K; Moriyama M; Nakamura Y
Neuroimmunomodulation; 2015; 22(4):243-9. PubMed ID: 25301694
[TBL] [Abstract][Full Text] [Related]
18. Tissue transglutaminase-mediated chemoresistance in cancer cells.
Verma A; Mehta K
Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.
Ku BM; Kim DS; Kim KH; Yoo BC; Kim SH; Gong YD; Kim SY
FASEB J; 2013 Sep; 27(9):3487-95. PubMed ID: 23704086
[TBL] [Abstract][Full Text] [Related]
20. Insights into the heparan sulphate-dependent externalisation of transglutaminase-2 (TG2) in glucose-stimulated proximal-like tubular epithelial cells.
Furini G; Burhan I; Huang L; Savoca MP; Atobatele A; Johnson T; Verderio EAM
Anal Biochem; 2020 Aug; 603():113628. PubMed ID: 32074489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
